CS logo
small CS logo
Studienzentrum Nord-West

Westerstede, Germany
Neurologe in Westerstede, Niedersachsen

About Studienzentrum Nord-West


  • Top Sponsors
  • Top Collaborators
  • Trials By Phase
  • Recruitment Status
  • Top Conditions
  • Intervention Types
  • Top Intervention Names
  • Trials By Gender
Lead Sponsor
# Trials
Boehringer Ingelheim
2
Alzheon Inc.
1
AstraZeneca
1
Avraham Pharmaceuticals Ltd
1
H. Lundbeck A/S
1
Neurocrine Biosciences
1
Pfizer
1
PharmatrophiX Inc.
1
Shire
1
Total Rows: 9

Clinical Trials at Studienzentrum Nord-West


During the past decade, Studienzentrum Nord-West conducted 7 clinical trials. In the 10-year time frame, 7 clinical trials started and 5 clinical trials were completed, i.e. on average, 71.4% percent of trials that started reached the finish line to date. In the past 5 years, 4 clinical trials started and 2 clinical trials were completed. i.e. 50% of trials that started reached the finish line.
Created with Highcharts 11.1.0TrialsTrials Trend - Last 10 Years221100221111110011000011Started TrialsCompleted Trails2017201820192020202120220123
Trials List
Trail ID
Brief Title
Start Date
Completion Date
Status
Enrollment
A 3 Year Study to Evaluate the Safety and Efficacy of Low Dose Ladostigil in Patients With Mild Cognitive Impairment
2012-02-01
2016-09-01
Completed
210
Evaluate the Maintenance of Efficacy of SPD489 in Adults Aged 18-55 Years With Moderate to Severe Binge Eating Disorder
2014-01-27
2015-04-08
Completed
418
An Efficacy and Safety Study of Lanabecestat (LY3314814) in Early Alzheimer's Disease
2014-09-30
2018-10-04
Terminated
2,218
Study of LM11A-31-BHS in Mild-moderate AD Patients
2017-02-15
2020-06-08
Completed
242
Clostridium Difficile Vaccine Efficacy Trial
2017-03-29
2021-12-21
Completed
17,535
A Study to Evaluate Efficacy, Safety, Tolerability, and Pharmacokinetics of 3 Dose Levels of TAK-831 in Adjunctive Treatment of Adult Participants With Negative Symptoms of Schizophrenia
2018-01-04
2021-01-12
Completed
307
A Study to Evaluate the Efficacy and Safety of Eptinezumab for the Prevention of Migraine in Participants That Are Not Helped by Previous Preventive Treatments
2020-06-01
2022-09-15
Completed
892
A Study to Test the Effect of Different Doses of BI 1358894 and Quetiapine in People With Depression
2020-11-20
2024-02-15
Recruiting
431

Rows per page:

1–10 of 10

Clinical Trials Sponsors and Collaborators


Out of the total clinical trials conducted in "Studienzentrum Nord-West" #1 sponsor was "Boehringer Ingelheim" with 2 trials, followed by "Alzheon Inc." with 1 trials sponsored, "AstraZeneca" with 1 trials sponsored, "Avraham Pharmaceuticals Ltd" with 1 trials sponsored and "H. Lundbeck A/S" with 1 trials sponsored. Other sponsors include -1 different institutions and companies that sponsored additional 9 trials in total.
In terms of collaborators to trials, out of the total clinical trials conducted in "Studienzentrum Nord-West" #1 collaborator was "National Institute on Aging (NIA)" with 2 trials as a collaborator, "Eli Lilly and Company" with 1 trials as a collaborator and "Takeda" with 1 trials as a collaborator. Other collaborators include -3 different institutions and companies that were collaborators in the rest 3 trials.
Created with Highcharts 11.1.0Top Leading SponsorsBoehringer Ingelheim: 2Boehringer Ingelheim: 2Alzheon Inc.: 1Alzheon Inc.: 1AstraZeneca: 1AstraZeneca: 1Avraham Pharmaceuticals Ltd: 1Avraham Pharmaceuticals Ltd: 1H. Lundbeck A/S: 1H. Lundbeck A/S: 1Neurocrine Biosciences: 1Neurocrine Biosciences: 1Pfizer: 1Pfizer: 1PharmatrophiX Inc.: 1PharmatrophiX Inc.: 1Shire: 1Shire: 1

Created with Highcharts 11.1.0Top CollaboratorsNational Institute onAging (NIA): 2National Institute onAging (NIA): 2Eli Lilly and Company: 1Eli Lilly and Company: 1Takeda: 1Takeda: 1

Clinical Trials Conditions at Studienzentrum Nord-West


According to Clinical.Site data, the most researched conditions in "Studienzentrum Nord-West" are "Schizophrenia" (2 trials), "Alzheimer´s Disease" (1 trials), "Binge Eating Disorder" (1 trials), "Clostridium Difficile Infection" (1 trials) and "Dementia" (1 trials). Many other conditions were trialed in "Studienzentrum Nord-West" in a lesser frequency.

Clinical Trials Intervention Types at Studienzentrum Nord-West


Most popular intervention types in "Studienzentrum Nord-West" are "Drug" (9 trials), "Biological" (1 trials) and "Other" (1 trials). Other intervention types were less common.
The name of intervention was led by "Placebo" (7 trials), "400mg LM11A-31-BHS" (1 trials), "800mg LM11A-31-BHS" (1 trials), "BI 1358894" (1 trials) and "BI 425809" (1 trials). Other intervention names were less common.

Clinical Trials Genders at Studienzentrum Nord-West


The vast majority of trials in "Studienzentrum Nord-West" are 10 trials for "All" genders.

Clinical Trials Status at Studienzentrum Nord-West


Currently, there are NaN active trials in "Studienzentrum Nord-West". undefined are not yet recruiting, 2 are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 6 completed trials in Studienzentrum Nord-West, undefined suspended trials, and 1 terminated clinical trials to date.
Out of the total trials that were conducted in Studienzentrum Nord-West, 1 "Phase 1" clinical trials were conducted, 5 "Phase 2" clinical trials and 6 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".
Created with Highcharts 11.1.0Trials By PhasePhase 3: 6Phase 3: 6Phase 2: 5Phase 2: 5Phase 1: 1Phase 1: 1

Created with Highcharts 11.1.0Trials StatusCompleted: 6Completed: 6Recruiting: 2Recruiting: 2Active, not recruiting: 1Active, not recruiting: 1Terminated: 1Terminated: 1